Page last updated: 2024-11-05

tosufloxacin and Leukemia P388

tosufloxacin has been researched along with Leukemia P388 in 1 studies

tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.

Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhao, YL1
Cai, SH1
Wang, L1
Kitaichi, K1
Tatsumi, Y1
Nadai, M1
Yoshizumi, H1
Takagi, K2
Hasegawa, T1

Other Studies

1 other study available for tosufloxacin and Leukemia P388

ArticleYear
Possible involvement of P-glycoprotein in the biliary excretion of grepafloxacin.
    Clinical and experimental pharmacology & physiology, 2002, Volume: 29, Issue:3

    Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B

2002